A commercial-stage medical device company developing automated insulin delivery systems and bionic pancreas technology for people with diabetes. The company's flagship product, the iLet Bionic Pancreas, is an FDA-cleared insulin delivery device designed for type 1 diabetes management in adults and children. Beta Bionics is also developing additional products including a patch pump system and bihormonal delivery solutions.